A meta analysis and hierarchical classification of HU-based atherosclerotic plaque characterization criteria

Wisnumurti Kristanto1, Peter M A van Ooijen, Marijke C Jansen-van der Weide

  • 1Department of Radiology, Center for Medical Imaging - North East, Netherlands, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Plos One
|September 11, 2013
PubMed

Insights

Computed tomography (CT) Hounsfield Unit (HU) criteria for characterizing atherosclerotic plaques vary widely. This study derived a hierarchical classification to establish reliable, local reference CT attenuation values for clinical use.

Area of Science:

  • Cardiovascular Imaging
  • Radiology
  • Medical Imaging Analysis

Background:

  • Lipid-rich atherosclerotic plaques, often rupture-prone, are characterized using computed tomography (CT) Hounsfield Unit (HU) values.
  • Existing HU-based criteria for plaque characterization show considerable variability in published literature.
  • A need exists for standardized, reliable HU criteria for clinical application.

Purpose of the Study:

  • To systematically analyze existing Hounsfield Unit (HU) criteria for characterizing lipid-rich and fibrous atherosclerotic plaques.
  • To empirically derive a hierarchical classification of HU-based criteria for clinical reference.
  • To address the significant variations in reported CT attenuation values.

Main Methods:

  • Conducted a systematic literature search (PubMed, Embase) for studies (1998-2011) using HU criteria for plaque characterization.
  • Analyzed HU criteria based on study characteristics (e.g., examination type, CT vendor, voltage settings).
  • Utilized Student's t-test to assess significant differences and developed a hierarchical classification.

Main Results:

  • No correlation was found between HU criteria and lumen contrast-enhancement.
  • Significant differences in HU criteria were observed based on various study characteristics.
  • The hierarchical classification yielded 21 categories for lipid-rich plaques and 22 for fibrous plaques, with over 50% differing significantly.

Conclusions:

  • Reported CT attenuation values for atherosclerotic plaques vary extensively, making generalized values unreliable for clinical practice.
  • The proposed hierarchical classification provides a framework for determining local, reliable reference CT attenuation values.
  • This classification aids in more consistent and accurate characterization of plaque composition in clinical settings.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...